Literature DB >> 22766889

Osteoporosis after solid organ transplantation.

C A M Kulak1, V Z Cochenski Borba, J Kulak, M Ribeiro Custódio.   

Abstract

Osteoporosis and high risk of fractures have emerged as frequent and devastating complications of organ solid transplantation process. Bone loss after organ transplant is related to adverse effects of immunosuppressive drugs on bone remodeling and bone quality. Many factors contribute to the pathogenesis of osteoporosis in transplanted patients. This review address the mechanisms of bone loss that occurs both in the early and late post-transplant periods including the contribution of the immunosuppressive agents as well as the specific features to bone loss after kidney, lung, liver and cardiac transplantation. Therapy for bone loss and prevention of fragility fracture in the transplant recipient will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766889

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  4 in total

1.  Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility.

Authors:  Georgios Vlachopanos; Julie M Bridson; Ajay Sharma; Ahmed Halawa
Journal:  World J Transplant       Date:  2016-12-24

2.  Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats.

Authors:  Mercedes Rubert; Mercedes Montero; David Guede; Jose-Ramón Caeiro; Marta Martín-Fernández; Manuel Díaz-Curiel; Concepción de la Piedra
Journal:  Bone Rep       Date:  2015-05-14

Review 3.  Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.

Authors:  Sophie Liabeuf; Lynda Cheddani; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2018-06-05       Impact factor: 4.546

Review 4.  Risk Factors and Management of Osteoporosis Post-Transplant.

Authors:  Karthik Kovvuru; Swetha Rani Kanduri; Pradeep Vaitla; Rachana Marathi; Shiva Gosi; Desiree F Garcia Anton; Franco H Cabeza Rivera; Vishnu Garla
Journal:  Medicina (Kaunas)       Date:  2020-06-19       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.